Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia Following Arthroscopic Shoulder Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-65
SponsorTanta University

About this trial

This study aims to evaluate the diaphragmatic movement and postoperative analgesia following anterior glenoid, suprascapular, and interscalene nerve blocks in patients undergoing elective arthroscopic shoulder surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 21 to 65 years.

Both sexes.

American Society of Anesthesiologists (ASA) physical status I or II.

Scheduled for arthroscopic shoulder surgery.

Disqualifiers

Patient's refusal to participate.

Patients with a history of allergy to local anesthetics.

Patients with a history of chronic use of painkillers.

Patients presented with mental dysfunction.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interscalene brachial plexus block

    Other intervention

    Patients will receive general anesthesia, plus an ultrasound-guided interscalene brachial plexus block (ISB) with the injection of 15 mL of 0.25% bupivacaine.

  • Suprascapular nerve block

    Other intervention

    Patients will receive general anesthesia plus an ultrasound-guided suprascapular nerve block (SSNB) with injection of 15 ml of 0.25% bupivacaine.

  • Anterior glenoid block

    Other intervention

    Patients will receive general anesthesia plus an ultrasound-guided anterior glenoid block with injection of 15 ml of 0.25% bupivacaine.

  • Suprascapular nerve block + Anterior glenoid block

    Other intervention

    Patients will receive general anesthesia, along with a total volume of 30 mL of 0.25% bupivacaine, divided into 15 mL for ultrasound-guided SSNB and 15 mL for ultrasound-guided anterior glenoid block.

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: Group IActive comparator 1 intervention
Group B: Group IIExperimental treatment 1 intervention
Group C: Group IIIExperimental treatment 1 intervention
Group D: Group IVExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of hemi-diaphragmatic paralysis

Incidence of hemi-diaphragmatic paralysis determined by ultrasound-guided assessment of diaphragmatic excursion. Diaphragmatic excursion will be measured before procedure (pre-block), 30 minutes after performing the block and post operative after complete recovery in post-anesthesia care unit (PACU).

Time frame
24 hours postoperatively

Secondary outcomes

1

Degree of pain

Each patient will be instructed about postoperative pain assessment with the numerical rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be recorded at T0, 30 min, 2, 4, 6, 12, 18, and 24 hours postoperatively.

Time frame
24 hours postoperatively
2

Total analgesic consumption

All patients will receive Paracetamol 1 g/6 hours as a regular analgesia and Morphine 3mg if the numerical rating scale (NRS) \> 3 as a rescue analgesia.

Time frame
24 hours postoperatively
3

Degree of patient satisfaction

The degree of patient satisfaction will be assessed based on a questionnaire and graded on a 4-point scale (excellent/good/fair/poor)

Time frame
24 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.